361 results on '"Savarino, E."'
Search Results
2. T.01.9 WHICH CHRONOPTYPE IS MORE FREQUENT IN PATIENTS WITH OBJECTIVE GERD AND HOW DOES IT AFFECT THE RESPONSE TO PPI THERAPY?
3. OC.16.4 ASSOCIATION BETWEEN SYSTEMIC SCLEROSIS SEVERITY AND HIGH RESOLUTION MANOMETRY FINDINGS
4. T.05.3 BASELINE ANXIETY SCORES PREDICT ESCALATION TO HIGHER DOSES OF PAROXETINE IN PATIENTS WITH FUNCTIONAL HEARTBURN AND REFLUX HYPERSENSITIVITY
5. T.05.2 DO WE NEED THREE DIFFERENT TYPES OF ESOPHAGOGASTRIC JUNCTION?
6. T.02.2 GUT EPITHELIAL PERMEABILITY IS ALTERED IN IBS PATIENTS: CORRELATIONS WITH SYMPTOMS AND UNDERLYING MOLECULAR MECHANISMS
7. PC.01.4 THE ROLE OF LARYNGOSCOPY IN GERD PATIENTS WITH ATYPICAL SYMPTOMS - A MULTICENTRE STUDY
8. T.01.6 THE EFFICACY OF SIX-FOOD ELIMINATION DIET IS LOWER DURING POLLEN SEASON IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS SENSITIZED TO POLLENS
9. OC.03.5 LONG-TERM EFFICACY OF PROTON PUMP INHIBITORS IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS
10. OC.16.2 STRAIGHT LEG RAISE TEST TO ASSESS ESOPHAGEAL CONTRACTION RESERVE IN NORMAL COMPARED TO INEFFECTIVE ESOPHAGEAL MOTILITY
11. T.05.1 IMPEDANCE-PH FINDINGS CONFIRM THAT GRADE B ESOPHAGITIS PROVIDES CONCLUSIVE DIAGNOSIS OF GASTROESOPHAGEAL REFLUX DISEASE
12. T.06.8 REAL WORD LONG-TERM EFFICACY AND SAFETY OF VEDOLIZUMAB IN MANAGING ULCERATIVE COLITIS VERSUS CROHN'S DISEASE: RESULTS FROM “LONG VEDO” ITALIAN MULTICENTER STUDY
13. OC.03.3 MOLECULAR AND MICROBIOTA PROFILING IN EOSINOPHILIC ESOPHAGITIS: A TRANSCRIPTOME AND META-TRANSCRIPTOME META-ANALYSIS
14. Quality of endoscopic screening for colorectal cancer in Italy: A national survey
15. T.01.1 APPLICATION OF LYON CONSENSUS CRITERIA FOR GERD DIAGNOSIS: EVALUATION OF PATIENTS WITH INCONCLUSIVE DIAGNOSIS AND NEW IMPEDANCE-PH PARAMETERS
16. T.01.6 STRAIGHT LEG RAISE TEST: A NOVEL PROVOCATIVE TEST TO ASSESS ESOPHAGEAL CONTRACTION RESERVE AT HIGH-RESOLUTION MANOMETRY
17. T.06.2 MANAGEMENT AND OUTCOME OF CHECK-POINT INHIBITORINDUCED COLITIS: A MULTICENTRE RETROSPECTIVE STUDY
18. OC.05.4 SYSTEMATIC REVIEW WITH META-ANALYSIS: ARTIFICIAL INTELLIGENCE IN THE DIAGNOSIS OF ESOPHAGEAL DISEASES
19. T.01.3 ASSOCIATION BETWEEN POST-REFLUX SWALLOW-INDUCED PERISTALTIC WAVE (PSPW) INDEX AND ESOPHAGEAL MUCOSAL INTEGRITY IN PATIENTS WITH GERD SYMPTOMS
20. OC.03.3 EOSINOPHILIC ESOPHAGITIS: MOST NON-RESPONDERS TO FIRST COURSE OF PPIS ACHIEVE SUSTAINED HISTOLOGICAL REMISSION FOLLOWING SEQUENTIAL TREATMENT WITH TOPICAL STEROIDS AND SECOND COURSE OF PPIS MONOTHERAPY
21. OC.11.5 IMPACT OF REFLUX BURDEN IN PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY ACCORDING TO THE CRITERIA PROPOSED BY CCV4.0 COMPARED TO CCV3.0
22. OC.01.5 RAPID DRINK CHALLENGE DURING HIGH RESOLUTION MANOMETRY IS USEFUL TO PREDICT ESOPHAGEAL EMPTYING IN ACHALASIA PATIENTS AFTER TREATMENT
23. AF.16 DIAGNOSTIC DELAY AND MISDIAGNOSIS IN EOSINOPHILIC ESOPHAGITIS
24. AF.15 EOSINOPHILIC ESOPHAGITIS IS FREQUENTLY ASSOCIATED WITH DISORDERS OF PERISTALSIS AT HIGH-RESOLUTION MANOMETRY: A PROSPECTIVE SINGLE-CENTRE CASE-CONTROL STUDY
25. AF.48 COMPARATIVE ASSESSMENT OF ADALIMUMAB TROUGH LEVELS BETWEEN POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (ENZYME LINKED IMMUNOSORBENT ASSAY) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
26. OC.01.10 EGJ OUTFLOW OBSTRUCTION ACCORDING TO THE NEW CHICAGO CLASSIFICATION: HOW MANY DIAGNOSES MIGHT BE CONFIRMED?
27. Combined multichannel intraluminal impedance and manometry testing
28. Normal values of 24-h ambulatory intraluminal impedance combined with pH-metry in subjects eating a Mediterranean diet
29. P.07.33 MICROENCAPSULATED SODIUM BUTYRATE SIGNIFICANTLY MODIFIES THE MICROBIOTA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE MIMICKING PREBIOTIC ACTIVITY AND PROVING EFFECTS ON THE TREATMENT OF THE DISEASE
30. T04.02.8 INFLIXIMAB ORIGINATOR, INFLIXIMAB BIOSIMILAR AND ADALIMUMAB ARE EQUALLY EFFECTIVE AND SAFE IN ULCERATIVE COLITIS AND CROHN'S DISEASE – A REAL-LIFE COHORT STUDY
31. T01.02.4 FECAL EOSINOPHIL CATIONIC PROTEIN AS POTENTIAL MARKER OF DISEASE ACTIVITY IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS
32. T01.02.8 EOSINOPHILIC ESOPHAGITIS - VISUAL SCORE: A NOVEL PICTORIAL SELF-ADMINISTERED TOOL TO ASSESS QUALITY OF LIFE IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS
33. T02.01.23 MEXILETINE INDUCED ESOPHAGEAL ULCERATION: TWO CASE REPORTS
34. T01.02.17 CLINICAL USEFULNESS OF SECOND-GENERATION BARRIER DRUGS IN GERD PATIENTS WITH ATYPICAL SYMPTOMS: A-6-MONTHS PROSPECTIVE STUDY
35. T01.02.13 EOSINOPHILIC ESOPHAGITIS QUALITY OF LIFE QUESTIONNAIRE WELL CORRELATES WITH DISEASE ACTIVITY AND RESPONSE TO THERAPY IN ACTIVE EOSINOPHILIC ESOPHAGITIS PATIENTS
36. T01.02.23 ROLE OF ENVIRONMENTAL FACTORS ON THE OUTCOME OF GASTROESOPHAGEAL REFLUX DISEASE: 6 MONTHS PROSPECTIVE STUDY
37. T01.02.3 LONG TERM TREATMENT WITH PROTON PUMP INHIBITORS AND TOPICAL STEROIDS IN EOSINOPHILIC ESOPHAGITIS: EFFICACY, MODALITY OF TAPERING AND FACTORS INFLUENCING OUTCOMES — A RETROSPECTIVE STUDY
38. T04.01.21 INTESTINAL MICROBIOTA CHANGES ACCORDING TO DISEASE ACTIVITY IN PATIENTS WITH ULCERATIVE COLITIS
39. T01.02.19 IS IT POSSIBILE TO WITHDRAW PPIS THERAPY IN GERD PATIENTS? A PROSPECTIVE STUDY ON 216 PATIENTS USING A SECOND GENARTION BARRIER DRUG
40. T01.02.21 ESOPHAGEAL MOTILITY DISORDERS IN EOSINOPHILIC ESOPHAGITIS
41. T01.02.18 ACHALASIA IS A COMMON FINDING IN PATIENTS WITH EOE UNDERGOING HIGH-RESOLUTION MANOMETRY
42. Air swallowing can be responsible for non-response of heartburn to high-dose proton pump inhibitor
43. Combined multichannel intraluminal impedance and pH-metry: a novel technique to improve detection of gastro-oesophageal reflux: Literature review
44. P.07.22 HIGH RESOLUTION ANORECTAL MANOMETRY FOR DETERMINATION OF ANORECTAL FUNCTION IN ULCERATIVE COLITIS DURING DISEASE ACTIVITY AND AFTER REMISSION
45. OC.09.3 INFLIXIMAB DOSE-REDUCTION IN INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS IN PROLONGED DEEP REMISSION: POTENTIAL IMPLICATIONS ON DE-ESCALATION STRATEGIES IN A REAL LIFE CLINICAL SETTING WITHOUT A THERAPEUTIC DRUG MONITORING (TDM) APPROACH
46. P.01.8 PROVOCATIVE TESTS DURING HIGH-RESOLUTION MANOMETRY MAY BE HELPFUL TO DISTINGUISH PATIENTS WITH EOSINOPHILIC ESOPHAGITIS RESPONDING TO PPI THERAPY
47. P.07.2 DISEASE ACTIVITY INFLUENCES DISABILITY AND QUALITY OF LIFE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE – A CROSS-SECTIONAL STUDY
48. OC.12.4 RAPID POINT-OF-CARE MONITORING OF ANTI-INFLIXIMAB ANTIBODIES AND CLINICAL SCORES IN INFLAMMATORY BOWEL DISEASE PATIENTS
49. P.01.25 CAN A NON-INVASIVE TEST PREDICT THE RESULTS OF PH-IMPEDANCE? PROSPECTIVE STUDY OF A COHORT OF PATIENTS WITH EXTRA-ESOPHAGEAL MANIFESTATIONS OF GERD
50. P.01.22 A NATIONAL SURVEY ON GASTROENTEROLOGY TRAINING IN ITALY: CURRENT LANDSCAPE AND FUTURE NEEDS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.